Yi Wen, PhD

Director
Eli Lilly and Company
Indianapolis, Indiana

Yi Wen is currently a Director at Eli Lilly and Company. He holds a PhD in Pharmaceutics from Duquesne University, and he completed a postdoctoral training at the University of Chicago. He has experience and interests in immunogenicity assessment and biomarkers.

Disclosure information not submitted.

Presentation(s):

• AAPS Therapeutic Product Immunogenicity Community Membership Meeting

  Monday, October 17, 2022
  5:00 PM – 6:00 PM ET

• A Total ADA Assay and Pre-Existing Antibodies to AAV9

  Tuesday, October 18, 2022
  3:30 PM – 3:45 PM ET